
Journal of Medicinal Chemistry p. 278 - 284 (1975)
Update date:2022-08-04
Topics:
Hoffmann
Stenberg
Ljunggren
Svensson
Nilsson
A series of omega dibenzylaminoalkylamines and related compounds have been prepared and tested as inhibitors of fibrin cross linking. This structural type was chosen in an attempt to develop noncompetitive inhibitors of fibrinoligase. By the combination o
View MoreContact:86-575-86132822,86-575-86085355
Address:No.418 Dadao West Road,Qixing Street,Xinchang, Zhejiang Province, China.
Jinhua City Mingzhu Pharmaceutical Co.,Ltd.
Contact:15857995878 0579-82207761
Address:No.169 Shenze Road, New Area,Jinpan Development Zone, Jinhua
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
website:http://www.angchenchem.com
Contact:+86-510-88302099 82327577
Address:Rm. 404/405, Floor 4th, No. 983 FengXiang Road, Wuxi, China
Chengdu Pukang Biotechnology Co., Ltd
Contact:+86-28-82550498
Address:No. 558 Rulin Road,Xinjin county,Chengdu city, China
Doi:10.1021/om030064t
(2003)Doi:10.3390/molecules15042631
(2010)Doi:10.1002/jps.2600550108
(1966)Doi:10.1080/00397919908085933
(1999)Doi:10.1002/hlca.19600430136
(1960)Doi:10.1135/cccc19741596
(1974)